Dermatology: 844-562-3376 | Gastroenterology: 785-354-8518 | Plastic Surgery: 785-271-2297
Kansas Medical Clinic, PA

Crohn’s Disease

This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms and endoscopy.

KMC Dermatology

Topeka, Lawrence, Emporia, Manhattan, Kansas City, Shawnee, Leawood, Olathe

KMC Gastroenterology

785-354-8518
2200 SW 6th Ave.
Topeka, KS 66606

Disclaimer

All information provided herein is for educational purposes only. If you have a medical condition, please consult a physician to get a proper diagnosis and treatment plan.

© Copyright 2018 - Kansas Medical Clinic, PA